Skip to content

Drug interactions

Lomitapide + Temsirolimus

Severity: Moderate

Lomitapide and Temsirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide inhibits P-glycoprotein and may increase temsirolimus exposure. Temsirolimus may in turn have effects on lomitapide, which is a sensitive CYP3A4 substrate. Both drugs can cause adverse effects such as gastrointestinal intolerance and raised liver enzymes.

What this interaction means in plain words

Lomitapide and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lomitapide belongs to Cardiovascular; Temsirolimus belongs to Oncology.

Evidence level: Low

Why it happens

Lomitapide inhibits P-glycoprotein efflux of temsirolimus, and the two drugs may share CYP3A4 handling.

What to do

Monitor liver enzymes and temsirolimus toxicity, and consider reducing the temsirolimus dose if adverse effects occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomitapide with Temsirolimus?

MediHelp rates the interaction as moderate. Lomitapide and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lomitapide inhibits P-glycoprotein and may increase temsirolimus exposure. Temsirolimus may in turn have effects on lomitapide, which is a sensitive CYP3A4 substrate. Both drugs can cause adverse effects such as gastrointestinal intolerance and raised liver enzymes.

How serious is the interaction between Lomitapide and Temsirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes and temsirolimus toxicity, and consider reducing the temsirolimus dose if adverse effects occur.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in